NHS Cornwall and Isles of Scilly has followed guidance from the Information Commissioner and adopted the healthcare publication scheme.
The scheme helps people access information about us, the decisions we make and how we spend public money.
The pages below will provide you with information on:
- our policies and procedures
- what our priorities are
- what we spend and how we spend it
- what we do
- who we are
Most of the information we produce is available on our website. However, some may be in hard copy only. You can also check if the information you are looking for is in our disclosure log. The disclosure log contains responses to all the freedom of information requests we have received.
Prescribing rebate scheme
NHS Cornwall and Isles of Scilly has a policy to agree and consider future prescribing rebates. The arrangements for the drugs are listed below. Information correct as of 14 April 2022.
Attention deficit hyperactivity disorder
Product: Xaggitin
Company: Ethypharm.
Type: For use in the treatment of attention deficit hyperactivity disorder (ADHD).
Start date: 1 August 2017.
End date: Rolling.
Aligned to PrescQIPP: Yes.
Anti-psychotic medicine
Product: Quetiapine Biquelle
Company: Aspire Pharma Limited.Type: Atypical anti-psychotic medicine.Start date: 1 July 2025.End date: 30 June 2026.Aligned to PrescQIPP: Yes.
Diabetes Devices
Product: FreeStyle Libre 2 Plus glucose monitoring device
Company: Abbott
Type: FreeStyle Libre 2 Plus glucose monitoring device
Start: Nov 2023
End: 01/06/2025 New contract 07/25 – 07/27 FSL2+
Inhalers
Product: Clenil Modulite
Company: Chiesi Limited.Type: Inhaler.Start date: 1 July 2025.End date: 30 June 2027.Aligned to PrescQIPP: Yes.
Product: Fostair NEXThaler
Company: Chiesi Limited.
Type: Inhaler.
Start date: 1 October 2023.
End date: 31/03/2026 PrescQIPP extension till 31/03/2029
Aligned to PrescQIPP: Yes.
Product: Fostair pMDI
Company: Chiesi Limited.
Type: Inhaler.
Start date: 1 October 2023.
End date: 31/03/2027 (extension letter 1year from April 2026)
Aligned to PrescQIPP: Yes.
Insomnia
Product: Slenyto (melatonin) Modified release 1mg and 5mg Minitablets
Start date: 1 November 2024.
End date: 31 October 2027.
Osteoporosis
Product: Zadenvi (denosumab) pre-filled syringe
Start date: 1 April 2026.
End date: 31 March 2028.
Pain relief
Product: Fencino
Company: Luye Pharma.
Type: Pain relief patch.
Start date: 1 April 2016.
End date: Rolling.
Aligned to PrescQIPP: Yes.
Product: Sevodyne transdermal patch
Start date: 1 August 2025.
End date: 31 July 2027.
Parkinson’s
Product: Pipexus
Company: Ethypharm.
Type: For use in the treatment for Parkinson’s.
Start date: 1 July 2018.
End date: Rolling.
Aligned to PrescQIPP: Yes.
PCSK9 Inhibitors
Product: Praluent (alirocumab)
Company: SanofiType: AutoinjectorStart date: July 2022End date: 30 June 2028Aligned to PrescQIPP: Yes
Product: Repatha (Evolocumab)
Company: AmgenType: AutoinjectorStart date: 1 November 2022End date: 30 November 2028Aligned to PrescQIPP: Yes
Glaucoma (eye treatment)
Product: Monopost (latanoprost) 50 mcg/ml
Start date: 1 July 2026.End date: 30 June 2028.
Page last reviewed: 26 August 2026